Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  CHIRAL TECHNOLOGY
A Global Strategic Business Report

This report analyzes the worldwide markets for Chiral Technology in US$ Million. Chiral Technology Enabling Products analyzed are Intermediates, Analytical, and Others. The specific end-use segments discussed are Pharmaceuticals, and Agrochemicals. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 39 companies including many key and niche players worldwide such as Albemarle Corporation, BASF AG, Cambrex Corp., Chiral Quest Inc., Dalco ChromTech AB, Daicel Chemical Industries Ltd., DSM Pharmaceutical Products, DowpharmaSM, Johnson Matthey PLC, Regis Technologies Inc., Shasun Chemicals and Drugs Limited, Solvias, Sigma Aldrich Corp, and Suven Life Sciences Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-1098  PAGES:    238
PRICE:    $3950  DATE:       April 2008
COMPANIES:  39  MARKET DATA TABLES:   82
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  CHIRAL TECHNOLOGY (Complete Report) Pages : 238   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS4$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Chiral Technology Enabling Products.....I-4
Chiral Intermediates.....I-4
Analytical Products.....I-4
Other Products.....I-4
Chiral Technology End-Use Products.....I-4
Pharmaceuticals.....I-4
Agrochemicals.....I-4
  
II. EXECUTIVE SUMMARY62$2250
  1. Introduction.....II-13 $700  
   An Insight into Chiral Technology.....II-1
Techniques Used for Achieving Single-Isomers.....II-1
1$100
   Table 1: World Chiral Technology Market (2002 & 2010): Percentage Breakdown of Revenues by Techniques- Traditional Methods, Asymmetric Methods, and Biological Methods (includes corresponding Graph/Chart).....II-2
Importance and Advancements.....II-2
2$600
  2. Global Market Overview.....II-43 $300  
   Outlook and Trends.....II-4
Good Tidings for Chiral Technology.....II-4
1$100
   Market Drivers.....II-5
Demand for Chiral-based Therapeutic Drugs Augments Growth.....II-5
New Legislations Push Chiral Technology Demand.....II-5
1$100
   Key Trends.....II-6
Organizations Extend Approaches.....II-6
Companies’ Association with Universities.....II-6
1$100
  3. Chiral Technology – An Overview.....II-79 $600  
   Definitions.....II-7
Chiral Technology Enabling Products.....II-7
Chiral Intermediates.....II-7
Analytical Products.....II-7
Other Products.....II-7
Chiral Technology End-Use Markets.....II-7
Pharmaceuticals.....II-7
1$100
   Agrochemicals.....II-8
Description.....II-8
1$100
   Functioning of Chiral Molecules.....II-9
Chiral Preparation Process.....II-9
Traditional Methods.....II-9
Biological Methods.....II-9
1$100
   Asymmetric Methods.....II-10
Chiral Separation.....II-10
Chromatography – The Widely Used Method for Separation.....II-10
1$100
   How it Works?.....II-11
Chiral Mobile Phase Additive (CMPA).....II-11
Chiral Stationary Phase (CSP).....II-11
1$100
   Chiral Recognition.....II-12
Protein Chiral Stationary Phases.....II-12
Carbohydrate Columns.....II-12
Pirkle Columns.....II-12
Crystallization.....II-12
1$100
   Solvent Extraction.....II-13
Kinetic Resolution.....II-13
1$100
   Capillary Electrophoresis.....II-14
Receptor Based Resolution.....II-14
Miscellaneous Separative Techniques.....II-14
Chiral Synthesis.....II-14
2$200
  4. Chiral Technology – Development vs. Acquisition.....II-162 $200  
   In-House Creation & Development.....II-16
Acquisition of Technology.....II-16
1$100
   “Economics” of Chiral Technology.....II-17
1$100
  5. Chiral Analysis Products.....II-184 $400  
   Chiral Analytical Chromatography.....II-18
Chiral Liquid Chromatography.....II-18
Supercritical Fluid Chromatography - Substitute to LC for Enantiomer
  Separations.....II-18
Chiral Gas Chromatography.....II-18
1$100
   Chiral Simulated Moving Bed Chromatography.....II-19
Partition Chromatography.....II-19
Adsorption Chromatography.....II-19
Computer Assisted Resolution.....II-19
1$100
   Chiral Polarimetry.....II-20
Other Chiral Analytical Techniques.....II-20
Calorimetry.....II-20
Differential Scanning Calorimetry (DSC).....II-20
Enzymatic Assay.....II-20
1$100
   Immunoassay.....II-21
Isotope Dilution.....II-21
Nuclear Magnetic Resonance (NMR).....II-21
X-Ray Crystallography.....II-21
1$100
  6. Application Markets.....II-2210 $800  
   Pharmaceuticals – The Largest Market.....II-22
Changing Face of the Pharmaceutical Industry.....II-22
Analysis of Chiral Drugs.....II-22
1$100
   Select Companies Involved in Chiral Technology Market.....II-23
Table 2: Single-Enantiomer Drugs Market Worldwide (2006): Sales of Select Leading Brands (In US$ Billion) (includes corresponding Graph/Chart).....II-23
1$300
   Drugs Built on Chiral Technology.....II-24
Analgesics.....II-24
Anesthetics.....II-24
Anti-Infective Products.....II-24
1$100
   Cardiovascular System (CVS) Products.....II-25
Angiotensin-Converting Enzyme (ACE) Inhibitors.....II-25
Beta-Blockers.....II-25
Calcium Channel Blockers.....II-25
Diuretics.....II-25
Vasodilators.....II-25
Central Nervous System (CNS) Agents.....II-25
Anticonvulsants.....II-25
1$100
   Sedatives and Tranquilizers.....II-26
Stimulants and Antidepressants.....II-26
Oncogenic (Cancer-Treatment) Products.....II-26
Biochemicals.....II-26
Oligonucleotides.....II-26
1$100
   Oxyacids.....II-27
Amino Acids.....II-27
Sugars and Other Oligosaccharides.....II-27
1$100
   Vitamins.....II-28
Peptides.....II-28
1$100
   Pesticides – A Thriving Market.....II-29
Herbicides.....II-29
Insecticides.....II-29
1$100
   Fungicides.....II-30
Other Products.....II-30
Liquid Crystals.....II-30
1$100
   Flavor and Aroma Chemicals.....II-31
1$100
  7. Chiral Isomerism.....II-322 $200  
   Organic Chemical Isomerism Types.....II-32
Structural Isomerism.....II-32
Chain Isomerism.....II-32
Position Isomerism.....II-32
Functional Group Isomerism.....II-32
Stereoisomerism.....II-32
1$100
   Dynamic Isomerism (Tautomerism).....II-33
Patents.....II-33
1$100
  8. Regulatory & Environmental Issues.....II-341 $100  
   Regulatory & Environmental Issues.....II-34
1$100
  9. Product Introductions.....II-352 $200  
   Degussa Develops Novel Processes to Synthesize (S) CAP.....II-35
Regis Technologies, Inc. Launches RegisPack Chiral.....II-35
Columns.....II-35
Sigma-Aldrich Introduces ChiroSolv™ Kits.....II-35
Sigma-Aldrich Launches Ascentis Express HPLC Columns.....II-35
1$100
   Evolved Nanomaterial Releases Revolutionary Analytical Chiral Column.....II-36
BASF Develops Novel Process to Produce Chiral Intermediates.....II-36
Chiral Quest Launches C3 TunePhos.....II-36
1$100
  10. Recent Industry Activity.....II-373 $300  
   Cambrex to Buy ProSyntest AS.....II-37
Johnson Matthey and X-Zyme Sign Licensing Agreement.....II-37
Chiral Quest Starts a New Production Facility.....II-37
Chiral Quest Completes Reverse Merger with Surg II.....II-37
DSM and IEP Extend Partnership.....II-37
1$100
   Shasun Chemicals Acquires Rhodia Pharma Solutions.....II-38
Sigma-Aldrich Corp Acquires Astec.....II-38
Solvias Receives License for MeOBIPHEP Catalyst Technology.....II-38
Codexis Acquires Juelich Fine Chemicals.....II-38
ChiroBlock Exits from Chiral Compounds Business.....II-38
Chiral Quest Opens New Facility in China.....II-38
Chiral Quest to Supply C3 TunePhos to Phoenix Chemicals.....II-38
1$100
   Lonza and Codexis Sign Agreement for Biocatalysis Process.....II-39
DSM Signs Licensing Agreement with Chiral Quest.....II-39
Chiral Quest Signs Distribution Agreement with Aldrich Chemical.....II-39
BASF and Solvias to Collaborate on Chiral Molecule Development.....II-39
Chiral Quest and Avantium Enter into Partnership.....II-39
1$100
  11. Focus on Select Players.....II-405 $500  
   Albemarle Corporation (USA).....II-40
BASF AG (Germany).....II-40
Cambrex Corp. (USA).....II-40
1$100
   Chiral Quest Inc (US).....II-41
Dalco ChromTech AB (Sweden).....II-41
Daicel Chemical Industries Ltd. (Japan).....II-41
DSM Pharmaceutical Products (Netherlands).....II-41
1$100
   DowpharmaSM (USA).....II-42
Johnson Matthey PLC (UK).....II-42
Regis Technologies Inc (USA).....II-42
1$100
   Shasun Chemicals and Drugs Limited (India).....II-43
Solvias (Switzerland).....II-43
Sigma Aldrich Corp (USA).....II-43
Suven Life Sciences Ltd. (USA).....II-43
2$200
  12. Global Market Perspective.....II-45   
   Table 3: World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-451$300
   Table 4: World Long-term Projections for Chiral Technology Enabling Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-461$300
   Table 5: World 10-Year Perspective for Chiral Technology Enabling Products by Geographic Region – Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-471$300
   Table 6: World Recent Past, Current & Future Analysis for Chiral Intermediates by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-481$300
   Table 7: World Long-term Projections for Chiral Intermediates by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-491$300
   Table 8: World 10-Year Perspective for Chiral Intermediates by Geographic Region – Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-501$300
   Table 9: World Recent Past, Current & Future Analysis for Chiral Analytical Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-511$300
   Table 10: World Long-term Projections for Chiral Analytical Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-521$300
   TABLE 11: World 10-Year Perspective for Chiral Analytical Products by Geographic Region –
  Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for
    Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-53
1$300
   Table 12: World Recent Past, Current & Future Analysis for Other Chiral Technology Enabling Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-541$300
   Table 13: World Long-term Projections for Other Chiral Technology Enabling Products by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-551$300
   Table 14: World 10-Year Perspective for Other Chiral Technology Enabling Products by Geographic Region – Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-561$300
   Table 15: World Recent Past, Current & Future Analysis for Chiral Technology in Pharmaceuticals by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-571$300
   Table 16: World Long-term Projections for Chiral Technology in Pharmaceuticals by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-581$300
   Table 17: World 10-Year Perspective for Chiral Technology in Pharmaceuticals by Geographic Region – Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-591$300
   Table 18: World Recent Past, Current & Future Analysis for Chiral Technology in Agrochemicals by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-601$300
   Table 19: World Long-term Projections for Chiral Technology in Agrochemicals by Geographic Region – US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-611$300
   Table 20: World 10-Year Perspective for Chiral Technology in Agrochemicals by Geographic Region – Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-621$300
III. MARKET27$1950
  1. The United States.....III-19 $725  
   A. Market Analysis.....III-1
Overview.....III-1
Product Introductions/Developments.....III-1
1$75
   Strategic Corporate Developments.....III-21$75
   Select Players.....III-3
Albemarle Corporation.....III-3
Cambrex Corp......III-3
1$75
   Chiral Quest Inc.....III-4
DowpharmaSM.....III-4
Regis Technologies Inc.....III-4
1$75
   Sigma Aldrich Corp.....III-5
Suven Life Sciences Ltd......III-5
1$75
   B. Market Analytics.....III-6
Table 21: US Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-6

Table 22: US Long-term Projections for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-6
1$150
   TABLE 23: US 10-Year Perspective for Chiral Technology Enabling Products by Product
  Segment – Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other
    Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-7
1$150
   Table 24: US Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-8

Table 25: US Long-term Projections for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-8
1$150
   Table 26: US 10-Year Perspective for Chiral Technology by End-Use Segment – Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2003, 2008 & 2012.....III-9
1$150
  2. Japan.....III-105 $450  
   A. Market Analysis.....III-10
Outlook.....III-10
Daicel Chemical Industries Ltd – A Major Player.....III-10
1$75
   B. Market Analytics.....III-11
Table 27: Japanese Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-11

Table 28: Japanese Long-term Projections for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-11
1$150
   Table 29: Japanese 10-Year Perspective for Chiral Technology Enabling Products by Product Segment – Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-121$150
   Table 30: Japanese Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-13

Table 31: Japanese Long-term Projections for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-13
1$150
   Table 32: Japanese 10-Year Perspective for Chiral Technology by End-Use Segment – Percentage Breakdown of Value Sales for Pharmaceuticals and Agrochemicals Markets for Years 2003, 2008 & 2012.....III-14
1$150
  3. Europe.....III-158 $675  
   A. Market Analysis.....III-15
Overview.....III-15
Product Introductions.....III-15
1$75
   Strategic Corporate Developments.....III-161$75
   Select Players.....III-17
BASF AG (Germany).....III-17
1$75
   Dalco ChromTech AB (Sweden).....III-18
DSM Pharmaceutical Products (Netherlands).....III-18
Johnson Matthey PLC (UK).....III-18
1$75
   Solvias (Switzerland).....III-19
B. Market Analytics.....III-19
Table 33: European Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-19
1$150
   Table 34: European Long-term Projections for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-20

Table 35: European 10-Year Perspective for Chiral Technology Enabling Products by Product Segment – Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-20
1$150
   Table 36: European Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-21

Table 37: European Long-term Projections for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-21
1$150
   Table 38: European 10-Year Perspective for Chiral Technology by End-Use Segment – Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2003, 2008 & 2012.....III-22
1$150
  4. Rest of World.....III-235 $675  
   A. Market Analysis.....III-23
Outlook.....III-23
India.....III-23
Chiral Drugs in Indian Market.....III-23
China-A Hub for Pharmaceutical Manufacturing.....III-23
Strategic Corporate Development.....III-23
Shasun Chemicals and Drugs Limited – A Major Indian Player.....III-23
1$75
   B. Market Analytics.....III-24
Table 39: Rest of World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-24
1$150
   Table 40: Rest of World Long-term Projections for Chiral Technology Enabling Products by Product Segment – Intermediates, Analytical, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-25

Table 41: Rest of World 10-Year Perspective for Chiral Technology Enabling Products by Product Segment – Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-25
1$150
   Table 42: Rest of World Recent Past, Current & Future Analysis for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-26

Table 43: Rest of World Long-term Projections for Chiral Technology by End-Use Segment – Pharmaceuticals, and Agrochemicals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-26
1$150
   Table 44: Rest of World 10-Year Perspective for Chiral Technology by End-Use Segment – Percentage Breakdown of Value Sales for Pharmaceuticals, and Agrochemicals Markets for Years 2003, 2008 & 2012.....III-271$150
IV. COMPETITIVE LANDSCAPE 138$995
  
Total Companies Profiled: 39 (including Divisions/Subsidiaries - 49 )

Region/Country                 Players


The United States                 30   
Canada                             1
Japan                              2
Europe                            14
     France                        4
     Germany                       2
     The United Kingdom            3
     Italy                         1
     Rest of Europe                4
Asia-Pacific (Excluding Japan)     2
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2008, Global Industry Analysts, Inc., USA.